Phase II Evaluation of Early Oral Estramustine, Oral Etoposide, and Intravenous Paclitaxel Combined With Hormonal Therapy in Patients With High-risk Metastatic Prostate Adenocarcinoma: Southwest Oncology Group S0032

✍ Scribed by David C. Smith; Cathy M. Tangen; Peter J. Van Veldhuizen Jr.; Grant W. Harrer; Ali Golshayan; Glenn M. Mills; Nicholas J. Vogelzang; Ian M. Thompson; Maha H.A. Hussain

• Book ID: 116953387
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 233 KB
• Volume: 77
• Category: Article
• ISSN: 0090-4295
• DOI: 10.1016/j.urology.2010.12.043